WO2003059436A3 - Compositions and methods for promoting myocardial and peripheral angiogenesis - Google Patents
Compositions and methods for promoting myocardial and peripheral angiogenesis Download PDFInfo
- Publication number
- WO2003059436A3 WO2003059436A3 PCT/US2002/041484 US0241484W WO03059436A3 WO 2003059436 A3 WO2003059436 A3 WO 2003059436A3 US 0241484 W US0241484 W US 0241484W WO 03059436 A3 WO03059436 A3 WO 03059436A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- promoting myocardial
- peripheral angiogenesis
- angiogenesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003559596A JP2005518409A (en) | 2001-12-21 | 2002-12-23 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
AU2002367033A AU2002367033B2 (en) | 2001-12-21 | 2002-12-23 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
EP02806521A EP1478383A4 (en) | 2001-12-21 | 2002-12-23 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
CA002470503A CA2470503A1 (en) | 2001-12-21 | 2002-12-23 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/027,015 | 2001-12-21 | ||
US10/027,015 US7232802B2 (en) | 2001-12-21 | 2001-12-21 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003059436A2 WO2003059436A2 (en) | 2003-07-24 |
WO2003059436A3 true WO2003059436A3 (en) | 2004-09-23 |
Family
ID=21835160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/041484 WO2003059436A2 (en) | 2001-12-21 | 2002-12-23 | Compositions and methods for promoting myocardial and peripheral angiogenesis |
Country Status (6)
Country | Link |
---|---|
US (2) | US7232802B2 (en) |
EP (1) | EP1478383A4 (en) |
JP (1) | JP2005518409A (en) |
AU (1) | AU2002367033B2 (en) |
CA (1) | CA2470503A1 (en) |
WO (1) | WO2003059436A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0896825B1 (en) | 1997-08-14 | 2002-07-17 | Sulzer Innotec Ag | Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors |
US8323341B2 (en) | 2007-09-07 | 2012-12-04 | Intrinsic Therapeutics, Inc. | Impaction grafting for vertebral fusion |
WO2009033100A1 (en) | 2007-09-07 | 2009-03-12 | Intrinsic Therapeutics, Inc. | Bone anchoring systems |
US7717961B2 (en) | 1999-08-18 | 2010-05-18 | Intrinsic Therapeutics, Inc. | Apparatus delivery in an intervertebral disc |
CA2425951C (en) | 1999-08-18 | 2008-09-16 | Intrinsic Therapeutics, Inc. | Devices and method for nucleus pulposus augmentation and retention |
US7220281B2 (en) | 1999-08-18 | 2007-05-22 | Intrinsic Therapeutics, Inc. | Implant for reinforcing and annulus fibrosis |
WO2004100841A1 (en) | 1999-08-18 | 2004-11-25 | Intrinsic Therapeutics, Inc. | Devices and method for augmenting a vertebral disc nucleus |
US7998213B2 (en) | 1999-08-18 | 2011-08-16 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
US7972337B2 (en) | 2005-12-28 | 2011-07-05 | Intrinsic Therapeutics, Inc. | Devices and methods for bone anchoring |
JP2007151608A (en) * | 2005-11-30 | 2007-06-21 | Med Solution Kk | Apparatus and program for quantitatively evaluating complexity of shape and travel of organ |
US20080159604A1 (en) * | 2005-12-30 | 2008-07-03 | Allan Wang | Method and system for imaging to identify vascularization |
GB0813659D0 (en) | 2008-07-25 | 2008-09-03 | Smith & Nephew | Fracture putty |
US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
JP5664992B2 (en) * | 2009-08-26 | 2015-02-04 | 国立大学法人名古屋大学 | Cell specific peptides and uses thereof |
KR101335203B1 (en) | 2010-03-26 | 2013-11-29 | 숙명여자대학교산학협력단 | Peptides for Promotion of Angiogenesis and the use thereof |
JP5808631B2 (en) | 2011-09-29 | 2015-11-10 | 富士フイルム株式会社 | Angiogenic scaffold and method for producing blood vessel for regenerative medicine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002674A1 (en) * | 1997-07-08 | 1999-01-21 | University Of Dundee | Peptides containing the motif igd and their use as cell migration modulators |
US20020040004A1 (en) * | 1998-10-16 | 2002-04-04 | Benedict James J. | Method of promoting natural bypass |
US6468960B1 (en) * | 1999-04-23 | 2002-10-22 | Prolifia, Inc. | Therapeutic compositions and methods for enhancing angiogenesis |
Family Cites Families (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5831210B2 (en) | 1973-04-09 | 1983-07-05 | 武田薬品工業株式会社 | antennae |
US4172128A (en) | 1975-03-26 | 1979-10-23 | Erhard Thiele | Process of degrading and regenerating bone and tooth material and products |
US4761471A (en) | 1980-08-04 | 1988-08-02 | The Regents Of The University Of California | Bone morphogenetic protein composition |
US4619989A (en) | 1981-05-05 | 1986-10-28 | The Regents Of The University Of Cal. | Bone morphogenetic protein composition |
US4455256A (en) | 1981-05-05 | 1984-06-19 | The Regents Of The University Of California | Bone morphogenetic protein |
JPS57144756A (en) | 1981-03-04 | 1982-09-07 | Koken Kk | Impermeable laminated film |
US5705477A (en) | 1982-09-24 | 1998-01-06 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions of transforming growth factor β(TGF-β) which promotes wound healing and methods for their use |
US5656587A (en) | 1982-09-24 | 1997-08-12 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Promotion of cell proliferation by use of transforming growth factor beta (TGF-β) |
US4529590A (en) | 1982-12-27 | 1985-07-16 | Leveen Robert F | Production of angiogenetic factor |
US5328695A (en) | 1983-03-22 | 1994-07-12 | Massachusetts Institute Of Technology | Muscle morphogenic protein and use thereof |
US4801299A (en) | 1983-06-10 | 1989-01-31 | University Patents, Inc. | Body implants of extracellular matrix and means and methods of making and using such implants |
US4596574A (en) | 1984-05-14 | 1986-06-24 | The Regents Of The University Of California | Biodegradable porous ceramic delivery system for bone morphogenetic protein |
US4620327A (en) | 1984-07-05 | 1986-11-04 | Caplan Arnold I | Process of adapting soluble bone protein for use in stimulating osteoinduction |
US4699788A (en) | 1984-08-20 | 1987-10-13 | Trustees Of Boston University | Angiogenic factor methods of extraction and method for producing angiogenesis |
JPH0678460B2 (en) | 1985-05-01 | 1994-10-05 | 株式会社バイオマテリアル・ユニバース | Porous transparent polyvinyl alcohol gel |
US4678470A (en) | 1985-05-29 | 1987-07-07 | American Hospital Supply Corporation | Bone-grafting material |
US4774227A (en) | 1986-02-14 | 1988-09-27 | Collagen Corporation | Collagen compositions for bone repair containing autogeneic marrow |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US6432919B1 (en) | 1986-07-01 | 2002-08-13 | Genetics Institute, Inc. | Bone morphogenetic protein-3 and compositions |
US5459047A (en) | 1986-07-01 | 1995-10-17 | Genetics Institute, Inc. | BMP-6 proteins |
US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US5543394A (en) | 1986-07-01 | 1996-08-06 | Genetics Institute, Inc. | Bone morphogenetic protein 5(BMP-5) compositions |
US5631142A (en) | 1986-07-01 | 1997-05-20 | Genetics Institute, Inc. | Compositions comprising bone morphogenetic protein-2 (BMP-2) |
US5187076A (en) | 1986-07-01 | 1993-02-16 | Genetics Institute, Inc. | DNA sequences encoding BMP-6 proteins |
US6150328A (en) | 1986-07-01 | 2000-11-21 | Genetics Institute, Inc. | BMP products |
US4743259A (en) | 1986-10-29 | 1988-05-10 | The University Of Virginia Alumni Patents Foundation | Use of demineralized bone matrix in the repair of segmental defects |
US4902296A (en) | 1986-10-29 | 1990-02-20 | The University Of Virginia Alumni Patents Foundation | Use of demineralized bone matrix in the repair of segmental defects |
US4834757A (en) | 1987-01-22 | 1989-05-30 | Brantigan John W | Prosthetic implant |
US4952404A (en) | 1987-06-19 | 1990-08-28 | President And Fellows Of Harvard College | Promotion of healing of meniscal tissue |
US5681353A (en) | 1987-07-20 | 1997-10-28 | Regen Biologics, Inc. | Meniscal augmentation device |
US5108438A (en) | 1989-03-02 | 1992-04-28 | Regen Corporation | Prosthetic intervertebral disc |
US5258043A (en) | 1987-07-20 | 1993-11-02 | Regen Corporation | Method for making a prosthetic intervertebral disc |
US4772287A (en) | 1987-08-20 | 1988-09-20 | Cedar Surgical, Inc. | Prosthetic disc and method of implanting |
US4863732A (en) | 1987-12-16 | 1989-09-05 | Collagen Corporation | Injectable composition for inductive bone repair |
US4895838A (en) | 1988-03-09 | 1990-01-23 | Trustees Of Boston University | Method for provoking angiogenesis by administration of angiogenically active oligosaccharides |
US4900673A (en) | 1988-03-28 | 1990-02-13 | President And Fellows Of Harvard College | Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
US5219576A (en) | 1988-06-30 | 1993-06-15 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
US5545229A (en) | 1988-08-18 | 1996-08-13 | University Of Medicine And Dentistry Of Nj | Functional and biocompatible intervertebral disc spacer containing elastomeric material of varying hardness |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5936035A (en) | 1988-11-21 | 1999-08-10 | Cohesion Technologies, Inc. | Biocompatible adhesive compositions |
US5356630A (en) | 1989-02-22 | 1994-10-18 | Massachusetts Institute Of Technology | Delivery system for controlled release of bioactive factors |
US5062845A (en) | 1989-05-10 | 1991-11-05 | Spine-Tech, Inc. | Method of making an intervertebral reamer |
US5100422A (en) | 1989-05-26 | 1992-03-31 | Impra, Inc. | Blood vessel patch |
DE69031483T2 (en) | 1989-08-02 | 1998-02-05 | Univ North Carolina | Process for the cross-linking of collagen and product produced thereby |
GB8927546D0 (en) | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
FR2659226B1 (en) | 1990-03-07 | 1992-05-29 | Jbs Sa | PROSTHESIS FOR INTERVERTEBRAL DISCS AND ITS IMPLEMENTATION INSTRUMENTS. |
US5342394A (en) | 1990-05-16 | 1994-08-30 | Olympus Optical Co., Ltd. | Apparatus for blocking a vein branch and method of blocking a vein branch |
EP0483944B1 (en) | 1990-10-31 | 1995-07-05 | El Gendler | Flexible membranes produced from organic bone matrix for skeletal repair and reconstruction |
AU651421B2 (en) | 1990-11-30 | 1994-07-21 | Celtrix Pharmaceuticals, Inc. | Use of a bone morphogenetic protein in synergistic combination with TGF-beta for bone repair |
ES2117045T3 (en) | 1990-12-21 | 1998-08-01 | Curative Tech Inc | ANGIOGENIC PEPTIDES. |
US5192326A (en) | 1990-12-21 | 1993-03-09 | Pfizer Hospital Products Group, Inc. | Hydrogel bead intervertebral disc nucleus |
US5047055A (en) | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
US5206023A (en) | 1991-01-31 | 1993-04-27 | Robert F. Shaw | Method and compositions for the treatment and repair of defects or lesions in cartilage |
US5171278A (en) | 1991-02-22 | 1992-12-15 | Madhavan Pisharodi | Middle expandable intervertebral disk implants |
US5390683A (en) | 1991-02-22 | 1995-02-21 | Pisharodi; Madhavan | Spinal implantation methods utilizing a middle expandable implant |
US5972884A (en) | 1991-03-11 | 1999-10-26 | Creative Biomolecules, Inc. | Morphogen treatment of gastrointestinal ulcers |
US5290763A (en) | 1991-04-22 | 1994-03-01 | Intermedics Orthopedics/Denver, Inc. | Osteoinductive protein mixtures and purification processes |
US5563124A (en) | 1991-04-22 | 1996-10-08 | Intermedics Orthopedics/ Denver, Inc. | Osteogenic product and process |
EP0516901A1 (en) | 1991-06-06 | 1992-12-09 | Richard L. Lindstrom | Method and apparatus of a serumfree medical solution |
EP0592562B1 (en) | 1991-06-25 | 1999-01-07 | Genetics Institute, Inc. | Bmp-9 compositions |
CA2117088A1 (en) | 1991-09-05 | 1993-03-18 | David R. Holmes | Flexible tubular device for use in medical applications |
US5741429A (en) | 1991-09-05 | 1998-04-21 | Cardia Catheter Company | Flexible tubular device for use in medical applications |
US5270300A (en) | 1991-09-06 | 1993-12-14 | Robert Francis Shaw | Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone |
US5304194A (en) | 1991-10-02 | 1994-04-19 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
DE69233022T2 (en) | 1991-11-04 | 2004-02-12 | Genetics Institute, LLC, Cambridge | RECOMBINANT BONE MORPHOGENETIC PROTEIN HETERODIMERS, COMPOSITIONS AND METHODS OF USE |
US5147374A (en) | 1991-12-05 | 1992-09-15 | Alfredo Fernandez | Prosthetic mesh patch for hernia repair |
US6120760A (en) | 1992-02-12 | 2000-09-19 | Biopharm Gesellschaft Zur Biotechnologischen Entwicklung | Growth/differentiation factors of the TGF-β family |
DE4210334A1 (en) | 1992-03-30 | 1993-10-07 | Stoess & Co Gelatine | Biodegradable, water-resistant polymer material |
US5413571A (en) | 1992-07-16 | 1995-05-09 | Sherwood Medical Company | Device for sealing hemostatic incisions |
JPH0648955A (en) | 1992-07-29 | 1994-02-22 | Morinaga Milk Ind Co Ltd | Activator for digestive tract cell |
US5800537A (en) | 1992-08-07 | 1998-09-01 | Tissue Engineering, Inc. | Method and construct for producing graft tissue from an extracellular matrix |
US5318957A (en) | 1992-09-02 | 1994-06-07 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating angiogenesis |
US5437288A (en) | 1992-09-04 | 1995-08-01 | Mayo Foundation For Medical Education And Research | Flexible catheter guidewire |
US5478739A (en) | 1992-10-23 | 1995-12-26 | Advanced Tissue Sciences, Inc. | Three-dimensional stromal cell and tissue culture system |
US5616490A (en) | 1992-12-07 | 1997-04-01 | Ribozyme Pharmaceuticals, Inc. | Ribozymes targeted to TNF-α RNA |
US5595722A (en) | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US5637480A (en) | 1993-05-12 | 1997-06-10 | Genetics Institute, Inc. | DNA molecules encoding bone morphogenetic protein-10 |
IL110589A0 (en) | 1993-08-10 | 1994-11-11 | Bioph Biotech Entw Pharm Gmbh | Growth/differentiation factor of the TGF- beta family |
US5425772A (en) | 1993-09-20 | 1995-06-20 | Brantigan; John W. | Prosthetic implant for intervertebral spinal fusion |
US5370660A (en) | 1993-11-01 | 1994-12-06 | Cordis Corporation | Apparatus and method for delivering a vessel plug into the body of a patient |
US5514180A (en) | 1994-01-14 | 1996-05-07 | Heggeness; Michael H. | Prosthetic intervertebral devices |
US5556429A (en) | 1994-05-06 | 1996-09-17 | Advanced Bio Surfaces, Inc. | Joint resurfacing system |
US5681310A (en) | 1994-07-20 | 1997-10-28 | Yuan; Hansen A. | Vertebral auxiliary fixation device having holding capability |
US5707962A (en) | 1994-09-28 | 1998-01-13 | Gensci Regeneration Sciences Inc. | Compositions with enhanced osteogenic potential, method for making the same and therapeutic uses thereof |
US5562736A (en) | 1994-10-17 | 1996-10-08 | Raymedica, Inc. | Method for surgical implantation of a prosthetic spinal disc nucleus |
US5824093A (en) | 1994-10-17 | 1998-10-20 | Raymedica, Inc. | Prosthetic spinal disc nucleus |
US5674296A (en) | 1994-11-14 | 1997-10-07 | Spinal Dynamics Corporation | Human spinal disc prosthesis |
US5846770A (en) | 1994-11-22 | 1998-12-08 | Genetics Institute, Inc. | DNA molecules encoding human chordin |
US5677276A (en) | 1994-12-23 | 1997-10-14 | La Jolla Cancer Research Foundation | Immobilization of peptides to hyaluronate |
US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5635372A (en) | 1995-05-18 | 1997-06-03 | Genetics Institute, Inc. | BMP-15 compositions |
WO1996041818A1 (en) | 1995-06-09 | 1996-12-27 | Drohan William N | Chitin hydrogels, methods of their production and use |
EP0768332B1 (en) | 1995-10-11 | 2001-03-28 | Sulzer Markets and Technology AG | Process for photooxidative treatment of collagen-containing tissues |
US6048964A (en) | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
EP1704878B1 (en) | 1995-12-18 | 2013-04-10 | AngioDevice International GmbH | Crosslinked polymer compositions and methods for their use |
US5645597A (en) | 1995-12-29 | 1997-07-08 | Krapiva; Pavel I. | Disc replacement method and apparatus |
US5800550A (en) | 1996-03-13 | 1998-09-01 | Sertich; Mario M. | Interbody fusion cage |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US5981489A (en) | 1996-07-18 | 1999-11-09 | Alza Corporation | Non-aqueous protic peptide formulations |
US5716416A (en) | 1996-09-10 | 1998-02-10 | Lin; Chih-I | Artificial intervertebral disk and method for implanting the same |
US5965403A (en) | 1996-09-18 | 1999-10-12 | Genetics Institute, Inc. | Nucleic acids encoding bone morphogenic protein-16 (BMP-16) |
US5928940A (en) | 1996-09-24 | 1999-07-27 | Creative Biomolecules, Inc. | Morphogen-responsive signal transducer and methods of use thereof |
US5827328A (en) | 1996-11-22 | 1998-10-27 | Buttermann; Glenn R. | Intervertebral prosthetic device |
US5776142A (en) | 1996-12-19 | 1998-07-07 | Medtronic, Inc. | Controllable stent delivery system and method |
US5815904A (en) | 1997-03-13 | 1998-10-06 | Intratherapeutics, Inc. | Method for making a stent |
US5800549A (en) | 1997-04-30 | 1998-09-01 | Howmedica Inc. | Method and apparatus for injecting an elastic spinal implant |
EP1040126A2 (en) | 1997-12-17 | 2000-10-04 | Curis, Inc. | Methods for maintaining or restoring tissue-appropriate phenotype of soft tissue cells |
US6211157B1 (en) | 1998-05-01 | 2001-04-03 | Sulzer Biologics, Inc. | Protein mixtures to induce therapeutic angiogenesis |
US6992066B2 (en) | 1998-10-16 | 2006-01-31 | Zimmer Orthobiologics, Inc. | Povidone-containing carriers for polypeptide growth factors |
WO2000055206A1 (en) | 1999-03-18 | 2000-09-21 | The Hope Heart Institute | Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor |
US20030104977A1 (en) | 2000-03-31 | 2003-06-05 | Ugo Ripamonti | Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
US7081240B1 (en) | 2000-06-28 | 2006-07-25 | Zimmer Orthobiologics, Inc. | Protein mixtures for wound healing |
US20020025340A1 (en) | 2000-08-30 | 2002-02-28 | Dyer Wallace K. | Methods and compositions for tissue augmentation |
US20020173453A1 (en) | 2000-12-15 | 2002-11-21 | Rama Akella | Method of treating renal injury |
-
2001
- 2001-12-21 US US10/027,015 patent/US7232802B2/en not_active Expired - Fee Related
-
2002
- 2002-12-23 JP JP2003559596A patent/JP2005518409A/en active Pending
- 2002-12-23 CA CA002470503A patent/CA2470503A1/en not_active Abandoned
- 2002-12-23 EP EP02806521A patent/EP1478383A4/en not_active Withdrawn
- 2002-12-23 WO PCT/US2002/041484 patent/WO2003059436A2/en active Application Filing
- 2002-12-23 AU AU2002367033A patent/AU2002367033B2/en not_active Ceased
-
2007
- 2007-06-13 US US11/762,219 patent/US7579322B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999002674A1 (en) * | 1997-07-08 | 1999-01-21 | University Of Dundee | Peptides containing the motif igd and their use as cell migration modulators |
US20020040004A1 (en) * | 1998-10-16 | 2002-04-04 | Benedict James J. | Method of promoting natural bypass |
US6468960B1 (en) * | 1999-04-23 | 2002-10-22 | Prolifia, Inc. | Therapeutic compositions and methods for enhancing angiogenesis |
Non-Patent Citations (2)
Title |
---|
CHERNOUSOV M. ET AL: "Role of the I-9 and III-1 modules of fibronectin in formation of an extracellular fibronectin matrix", J. BIOL. CHEM., vol. 266, no. 17, 15 June 1991 (1991-06-15), pages 10851 - 10858, XP002197279 * |
See also references of EP1478383A4 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002367033B2 (en) | 2008-04-17 |
JP2005518409A (en) | 2005-06-23 |
EP1478383A2 (en) | 2004-11-24 |
AU2002367033A1 (en) | 2003-07-30 |
US20050143312A1 (en) | 2005-06-30 |
US7579322B2 (en) | 2009-08-25 |
WO2003059436A2 (en) | 2003-07-24 |
US7232802B2 (en) | 2007-06-19 |
EP1478383A4 (en) | 2006-05-10 |
CA2470503A1 (en) | 2003-07-24 |
US20070287671A1 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003059436A3 (en) | Compositions and methods for promoting myocardial and peripheral angiogenesis | |
WO2003096972A3 (en) | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof | |
WO2004061456A3 (en) | Uses of hmgb, hmgn, hmga proteins | |
PL1641914T3 (en) | Postpartum cells derived from placental tissue, and methods of making and using the same | |
WO2000069449A3 (en) | Conditioned cell culture medium compositions and methods of use | |
WO1999036570A3 (en) | Transglutaminase linkage of agents to tissue | |
AU4860900A (en) | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells | |
WO2004076631A3 (en) | Biologically active native biomatrix composition | |
AU2001275339A1 (en) | Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury | |
ATE446776T1 (en) | VESSEL COATING COMPOSITION | |
ATE260124T1 (en) | MATERIAL COMPOSITION FOR TISSUE FORMATION | |
BR0015148A (en) | Androgenetic or gynogenetic production of pluripotent cell and cell lines, and their use to produce differentiated tissues and cells | |
WO2002002593A3 (en) | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof | |
WO2002036771A3 (en) | Imaging, diagnosis and treatment of disease | |
AU6569600A (en) | Method for embellishing the shape of a human body by means of a cosmetic plaster | |
NO971341L (en) | Promoter for receptor tyrosine kinase TIE | |
WO2003046161A3 (en) | Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells | |
DE60001555D1 (en) | AQUEOUS SOLUTION FOR PRESERVING TISSUE AND ORGANS | |
WO2002098361A3 (en) | T cell induced tissue repair and regeneration | |
DK1185621T3 (en) | Surface for cell culture | |
WO2002058718A3 (en) | Use of compositions containing pdgf-bb for promoting angiogenesis | |
IL183711A0 (en) | Peptide fraction promoting growth and synthesis of desired product(s) into cell and/or tissue culture | |
WO2003000222A3 (en) | Cosmetic preparation with anti-wrinkle action | |
ZA200207590B (en) | Production of recombinant blood clotting factors in human cell lines. | |
WO1997040073A3 (en) | Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002367033 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2470503 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003559596 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002806521 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002806521 Country of ref document: EP |